Reach Us +441902928240
Platelet Glycoprotein IIB/IIIA Polymorphism And Its Role In Recurrent Early Pregnancy Loss | 103449
ISSN: 2157-7633

Journal of Stem Cell Research & Therapy
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Platelet glycoprotein IIB/IIIA polymorphism and its role in recurrent early pregnancy loss

Joint Event on 12th Annual Conference on Stem Cell and Regenerative Medicine & 4th Annual Conference on Biomaterials

Sameh K Sadek

University of Alexandria, Egypt

Posters & Accepted Abstracts: J Stem Cell Res Ther

DOI: 10.4172/2157-7633-C2-036

Recurrent pregnancy loss (RPL) is one of the Most frustrating and difficult areas in reproductive medicine because the etiologic is often unknown and there are few evidence-based diagnostic and treatment strategies. RPL is defined as two or more failed clinical pregnancies as documented by ultrasonography or histopathology examination. Approximately 15 percent of pregnant women experience sporadic loss of a clinically recognized pregnancy. Just 2 percent of pregnant women experience two consecutive pregnancy losses and only 0.4 to 1 percent have three consecutive pregnancy losses. Couples who have had a pregnancy loss have two major concerns: the cause and the risk of recurrence. Unfortunately, the cause of RPL can be determined in only 50 percent of patients. General etiological categories of RPL include anatomic, immunological, genetic, endocrine, thrombophilia, and environmental factors. Thrombophilia is an abnormality of blood coagulation that increases the risk of thrombosis. A significant proportion of the population has a detectable abnormality in blood, but most of these only develop thrombosis in the presence of an additional risk factor. The human glycoprotein (GP)IIb/IIIa is one of the best characterized receptors present on the surface of platelets. GPIIb/IIIa belongs to the large family of adhesion molecules called integrins, which share a common heterodimeric structure. The primary function of GPIIb/IIIa is to aid platelet aggregation. Nearly 20 years ago, Savage et al. demonstrated that the GPIIb/IIIa on the membrane of nonactivated platelets serves as a specific receptor for surfacebound fibrinogen but, after platelet activation this receptor acquires the ability to interact with other adhesive proteins, such as vitronectin, fibronectin and von Willebrand factor.

Sameh K Sadek is Associates Professor in University of Alexandria and hé is member of Clinical pathology Department, Faculty of Médicine, and Alexandria University. He completed Phd on infertility pregnancy and he is Assistant Professor in Gynaecology department in Alexandria. He has done nearly 25 publications and went to many summits as guest speaker.

E-mail: [email protected]


Leave Your Message 24x7